Invention Grant
- Patent Title: Nucleic acids encoding engineered anti-IL-23R antibodies
- Patent Title (中): 编码工程化抗IL-23R抗体的核酸
-
Application No.: US13671371Application Date: 2012-11-07
-
Publication No.: US08691532B2Publication Date: 2014-04-08
- Inventor: Leonard G. Presta
- Applicant: Leonard G. Presta
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Gregory R. Bellomy
- Main IPC: C12N15/09
- IPC: C12N15/09
Abstract:
Antibodies to human IL-23R are provided, as well as uses thereof, e.g. in treatment of inflammatory, autoimmune, and proliferative disorders.
Public/Granted literature
- US20130064817A1 ENGINEERED ANTI-IL-23R ANTIBODIES Public/Granted day:2013-03-14
Information query
IPC分类:
